Adoptive cell immunotherapies for cancer
In this webinar, our panelists will discuss recent developments and challenges for adoptive cell therapies for cancer treatment. Our spea…
In this webinar, our panelists will discuss recent developments and challenges for adoptive cell therapies for cancer treatment. Our spea…
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
The U.S. FDA’s panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress…
AUA 2024 comparison of mitomycin C vs BCG treatment, non-muscle invasive bladder cancer, International Bladder Cancer Group (IBCG), Kaplan-Meier analysis.
Latticework Capital Management said it exceeded its goal for its second healthcare fund.Â
Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its…
Rashid Sayyid and Zach Klaassen discuss the AUA’s updated guidelines for managing lower urinary tract symptoms due to BPH, with a focus on medical therapy.…
AUA 2024, photodynamic diagnosis (PDD), Photodynamic Diagnosis-Guided Biopsy,Bladder Mapping Biopsy, BCG therapy for bladder cancer, photodynamic diagnosis by anatomical location.
“It was very much about following the algorithms and basically not using your clinical judgment,” one former NaviHealth medical reviewer said. “That was very different…